EEU - pharmacokinetic equation??? [Power / Sample Size]

posted by mittyri – Russia, 2017-12-29 14:11 (1005 d 07:28 ago) – Posting: # 18126
Views: 26,849

Hi Yura,

» So I understand: imagine the power analysis and draw a conclusion (at low power) that since bioequivalence is established, a posteriori power rating does not affect the findings of the study
Yep. Once again: to be lucky is not a crime :-D
and vice versa: if the post-hoc power is -> 100%, you're a hero even if the study was overpowered de facto (i.e. CI [0.98-1.03]).

» More interesting question: the pharmacokinetic equation and its analysis ... :confused:
Good question! Next question!
Seems like they are interested in PK model which is not permitted. No clue so far :-|

Kind regards,

Complete thread:

 Admin contact
21,086 posts in 4,398 threads, 1,468 registered users;
online 15 (1 registered, 14 guests [including 2 identified bots]).
Forum time: Tuesday 22:39 CEST (Europe/Vienna)

To know the history of science is to recognize the mortality
of any claim to universal truth.    Evelyn Fox Keller

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz